Immunomodulatory Effects of Tyrosine Kinase Inhibitor In Vitro and In Vivo Study-Reference-Cited by-同舟云学术

Immunomodulatory Effects of Tyrosine Kinase Inhibitor In Vitro and In Vivo Study

Published:2018-02 Issue:2 Volume:24 Page:267-275
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Marinelli Busilacchi Elena,Costantini Andrea,Viola Nadia,Costantini Benedetta,Olivieri Jacopo,Butini Luca,Mancini Giorgia,Scortechini Ilaria,Chiarucci Martina,Poiani Monica,Poloni Antonella,Leoni Pietro,Olivieri Attilio

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference44 articles.

1. Graft-versus-host disease;Ferrara;Lancet,2009

2. Chronic GVHD as an autoimmune disease;Tyndall;Best Pract Res Clin Haematol,2008

3. Chronic graft-versus-host disease: biological insights from preclinical and clinical studies;MacDonald;Blood,2017

4. Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease;Svegliati;Blood,2007

5. The biology of chronic graft-versus-host disease: a task force report from the National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease;Cooke;Biol Blood Marrow Transplant,2017

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A lower initial dose of bosutinib for patients with chronic myeloid leukemia patients resistant and/or intolerant to prior therapy: a single-arm, multicenter, phase 2 trial (BOGI trial);International Journal of Hematology;2024-08-13

2. Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging;Pharmaceutics;2023-03-11

3. Repurposing Ponatinib as a PD-L1 Inhibitor Revealed by Drug Repurposing Screening and Validation by In Vitro and In Vivo Experiments;ACS Pharmacology & Translational Science;2023-01-12

4. Effects of the STAMP-inhibitor asciminib on T cell activation and metabolic fitness compared to tyrosine kinase inhibition by imatinib, dasatinib, and nilotinib;Cancer Immunology, Immunotherapy;2023-01-05

5. Regulatory T-cells and allogeneic hematopoietic stem cell transplantation;Transplantologiya. The Russian Journal of Transplantation;2022-12-20